维普期刊资源整合服务平台（V6.5）

129篇 您的检索式：作者名="MAKI RG"

选中清除导出查看参考文献查看引证文献引用追踪共7页首页上一页第1页下一页末页 /7 跳转

	题名	作者	年代	出处	被引量
1	Primary and secondary kinase genotypes correlate with the biological and clinical activity of sunitinib in imatinib-resistant gastrointestinal stromal tumor显示文摘	Heinrich MC Maki RG Corless CL	2008	J Clin Oncol2008，26，33：	1
2	Multicenter phase Ⅱ trial of sunitinib in the treatment of nongastrointestinal stromal tumor sarcomas显示文摘	George S Merriam P Maki RG	2009	J Clin Oncol2009，27，19：	1
3	IGF2 over-expression in solitary fibrous tumours is independent of anatomical location and is related to loss of imprinting显示文摘	Hajdu M Singer S Maki RG	2010	J Pathol2010，221，3：	1
4	Advanced soft-tissue sarco- ma in elderly patients: patterns of care and survival 显示文摘	Garbay D Maki RG Blay JY	2013	Ann On- col2013，24，7：	1
5	Evidence-based recommendations for local therapy for soft tissue sarcomas显示文摘	Pister PW O' sullivan B Maki RG	2007	J Clin Oncol2007，25，8：	1
6	Phase Ⅱ and pharmacokinetic study of ecteinascidin 743 in patients with progressive sarcomas of soft tissues refractory to chemotherapy显示文摘	Garcia-Carbonero R Supko JG Maki RG	2005	J Clin Oncol2005，23，24：	1
7	Primary and secondary kinase genotypes correlate with the biological and clinical activity of sunitinib in imatinib-resistant gastrointestinal stromal tumor 显示文摘	Heinrich MC Maki RG Corless CL	2008	J Clin Oncol2008，26，33：	1
8	Multicenter phase Ⅱ trial of sunitinib in the treatment ofnongastrointestinal stromal tumor sarcomas显示文摘	George S Merriam P Maki RG		0，，19：	1
9	Activity of sorafenib(SOR) in patients (pts) with imatinib (IM) and sunitinib (SU)-resistant (RES) gastrointestinal stromal tumors (GIST):A phase Ⅱ trim of the University of Chicago Phase Ⅱ Consortium 显示文摘	Wiebe L Kasza KE Maki RG	2008	J Clin Oncol2008，26，10：	1
10	Phase II study of sor- afenib in patients with metastatic or recurrent sarcomas显示文摘	Maki RG D'Adamo DR Keohan ML	2009	J Clin Onco12009，27，19：	1
11	Gemcitabine and docetaxel in metastatic sarcoma: past, present, and future显示文摘	Maki RG	2007	Oncologist2007，12，8：	1
12	Eribulin in soft-tissue sarcomas 显示文摘	Maki RG	2011	Lancet Oncol2011，12，11：	1
13	Opportunities for improving the therapeutic ratio for patients with sarcoma显示文摘	Wander JS Nielsen TO Maki RG	2007	Lancet Oncol2007，8，6：	1
14	Primary and secondary kinase genotypes correlate with the biological and clinical activity of sunitinib in imatinib-resistant gastrointestinal stromal tumor显示文摘	Heinrich MC Maki RG Corless CL	2008	J Clin Oncol2008，26，：	1
15	Randomized phase II study of gemcitabine and docetaxel compared with gemcitabine alone in patients with metastatic soft tissue sarcomas:results of sarcoma alliance for research through collaboration study 002 [corrected]显示文摘	Maki RG Wathen JK Patel SR		0，，：	1
16	Adjuvant therapy for highgrade,uterus -limited leiomyosarcoma: results of a phase 2 trial(SARC005)显示文摘	Hensley ML Wathen JK Maki RG	2013	Cancer2013，119，8：	1
17	Opportunities for improving the therapeutic ratio for patients with sarcoma显示文摘	Wunder JS Nielsen TO Maki RG	2007	Lancet Oncol2007，8，6：	1
18	Results of tyrosine kinase inhibitor therapy followed by surgical resection for metastatic gastrointestinal stromal tumor显示文摘	DeMatteo RP Maki RG Singer S	2007	Ann Surg2007，245，3：	1
19	Adjuvant therapy for high-grade,uterus-limited leiomyosarcoma:results of a phase 2 trial(SARC 005)显示文摘	Hensley ML Wathen JK Maki RG		0，，：	1
20	Primary and secondary kinase genotypes correlate with the biological and clinical activity of sunitinib in imatinib-resistant gastrointestinal stromal tumor显示文摘	Heinrich MC Maki RG Corless CL	2008	J Clin Oncol2008，26，33：	1

返回顶部每页显示：

共7页首页上一页第1页下一页末页 /7 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示